Modifying three-dimensional scaffolds from novel nanocomposite materials using dissolvable porogen particles for use in liver tissue engineering

被引:11
作者
Adwan, Hussamuddin [1 ]
Fuller, Barry [1 ]
Seldon, Clare [2 ]
Davidson, Brian [1 ]
Seifalian, Alexander [1 ]
机构
[1] UCL, Royal Free Hosp, Univ Dept Surg, London, England
[2] UCL, Royal Free Hosp, Ctr Hepatol, London, England
关键词
POSS-modified polycaprolactone urea urethane; nanocomposite polymers; hepatocytes; tissue engineering; scaffolds; porogens; HepG2; POROUS POLYMER MATRICES; IN-VITRO; BIOARTIFICIAL LIVER; HEPATOCYTE TRANSPLANTATION; ARTIFICIAL LIVER; CULTURE-SYSTEM; SILSESQUIOXANE NANOCOMPOSITES; CELL-LINE; SUPPORT; PROMETHEUS;
D O I
10.1177/0885328212445404
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background: Although hepatocytes have a remarkable regenerative power, the rapidity of acute liver failure makes liver transplantation the only definitive treatment. Attempts to incorporate engineered three-dimensional liver tissue in bioartificial liver devices or in implantable tissue constructs, to treat or bridge patients to self-recovery, were met with many challenges, amongst which is to find suitable polymeric matrices. We studied the feasibility of utilising nanocomposite polymers in three-dimensional scaffolds for hepatocytes. Materials and methods: Hepatocytes (HepG2) were seeded on a flat sheet and in three-dimensional scaffolds made of a nanocomposite polymer (Polyhedral Oligomeric Silsesquioxane [POSS]-modified polycaprolactone urea urethane) alone as well as with porogen particles, i.e. glucose, sodium bicarbonate and sodium chloride. The scaffold architecture, cell attachment and morphology were studied with scanning electron microscopy, and we assessed cell viability and functionality. Results: Cell attachment to the scaffolds was demonstrated. The scaffold made with glucose particles as porogen showed a narrower range of pore size with higher porosity and better inter-pore communications and seemed to encourage near normal cell morphology. There was a steady increase of albumin secretion throughout the experiment while the control (monolayer cell culture) showed a steep decrease after day 7. At the end of the experiment, there was no significant difference in viability and functionality between the scaffolds and the control. Conclusion: In this initial study, porogen particles were used to modify the scaffolds produced from the novel polymer. Although there was no significance against the control in functionality and viability, the demonstrable attachment on scanning electron microscopy suggest potential roles for this polymer and in particular for scaffolds made with glucose particles in liver tissue engineering.
引用
收藏
页码:250 / 261
页数:12
相关论文
共 45 条
[1]  
Allen JR, 2002, PLOUGHSHARES, V28, P8
[2]   Advances in bioartificial liver devices [J].
Allen, JW ;
Hassanein, T ;
Bhatia, SN .
HEPATOLOGY, 2001, 34 (03) :447-455
[3]   Nanocomposite containing bioactive peptides promote endothelialisation by circulating progenitor cells:: An in vitro evaluation [J].
Alobaid, N. ;
Salacinski, H. J. ;
Sales, K. M. ;
Ramesh, B. ;
Kannan, R. Y. ;
Hamilton, G. ;
Seifalian, A. M. .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2006, 32 (01) :76-83
[4]   Injectable liver:: A novel approach using fibrin gel as a matrix for culture and intrahepatic transplantation of hepatocytes [J].
Bruns, H ;
Kneser, U ;
Holzhüter, S ;
Roth, B ;
Kluth, J ;
Kaufmann, PM ;
Kluth, D ;
Fiegel, HC .
TISSUE ENGINEERING, 2005, 11 (11-12) :1718-1726
[5]   Artificial liver support in the third millennium [J].
Chamuleau, RAFM .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2003, 31 (02) :117-126
[6]   Toward development of an implantable tissue engineered liver [J].
Davis, MW ;
Vacanti, JP .
BIOMATERIALS, 1996, 17 (03) :365-372
[7]   Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: A randomized controlled study [J].
Dethloff, Thomas ;
Tofteng, Flemming ;
Frederiksen, Hans-Lorgen ;
Hojskov, Michael ;
Hansen, Bent Adel ;
Larsen, Fin Stolze .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (13) :2065-2071
[8]   MARS and prometheus: Our clinical experience in acute chronic liver failure [J].
Faenza, S. ;
Baraldi, O. ;
Bernardi, M. ;
Bolondi, L. ;
Coli, L. ;
Cucchetti, A. ;
Donati, G. ;
Gozzetti, F. ;
Lauro, A. ;
Mancini, E. ;
Pinna, A. D. ;
Piscaglia, F. ;
Rasciti, L. ;
Ravaioli, M. ;
Ruggeri, G. ;
Santoro, A. ;
Stefoni, S. .
TRANSPLANTATION PROCEEDINGS, 2008, 40 (04) :1169-1171
[9]   Influence of flow conditions and matrix coatings on growth and differentiation of three-dimensionally cultured rat hepatocytes [J].
Fiegel, HC ;
Havers, J ;
Kneser, U ;
Smith, MK ;
Moeller, T ;
Kluth, D ;
Mooney, DJ ;
Rogiers, X ;
Kaufmann, PM .
TISSUE ENGINEERING, 2004, 10 (1-2) :165-174
[10]   Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory [J].
Fiegel, Henning C. ;
Kaufmann, Peter M. ;
Bruns, Helge ;
Kluth, Dietrich ;
Horch, Raymund E. ;
Vacanti, Joseph P. ;
Kneser, Ulrich .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2008, 12 (01) :56-66